Together with our team members across Europe, the U.S., and Japan, we deliver development and manufacturing of mammalian and microbial-based therapeutic proteins, plasmid DNA (pDNA), messenger RNA (mRNA), viral vectors, and genetically engineered cells therapies. Analyze and report on client- and project-level profitability, partnering with operations and project management to identify margin drivers and ensure profitability targets are met.